Search - tctmd.com

Displaying 1 - 20 of 204

Sort: Relevancy | Date

Presentation TCT 2025

The Evolution of TAVR Explants

Presenter: Shinichi Fukuhara

October 28, 2025

Presentation TCT 2025

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

Presenter: Colin Jamieson

October 27, 2025

Presentation TCT 2025

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Presenter: Keith B. Allen

October 26, 2025

Presentation TCT 2025

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Presenter: Stephane Noble

October 26, 2025

Presentation TCT 2025

Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward

Presenter: Stephane Rinfret

October 26, 2025

Presentation TCT 2025

How I Treat A Failed Evolut

Presenter: Adnan K. Chhatriwalla

October 26, 2025

Presentation TCT 2025

A New FDA for a New Era: Innovation Demands Evolution!

Presenter: Michael R. Jaff

October 25, 2025

Presentation TCT 2025

TCT 1317: Preventing Sinus Sequestration in a Failed Evolut With ShortCut: A Dedicated Leaflet Modification Device

Presenter: Bassem M. Chehab

October 25, 2025

Presentation TCT 2025

TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice

Presenter: Guilherme Attizzani

October 25, 2025

Presentation TCT 2025

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

Presenter: Aoi Omori

October 25, 2025

Presentation TCT 2025

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Presenter: Akihiro Tobe

October 25, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

The Evolution of LAAO: Innovation Trends in Technology and Imaging

Presenter: Thomas Waggoner

October 30, 2024

Presentation TCT 2024

TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium

Presenter: Yair Feld

October 30, 2024

Presentation TCT 2024

AS in Women

Presenter: Renuka Jain

October 29, 2024

Presentation TCT 2024

Procedural Considerations

Presenter: Kendra Grubb

October 29, 2024

Presentation TCT 2024

Case Background and Valve Selection Discussion

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

Case Outcome

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

SMART Data

Presenter: Howard Herrmann

October 29, 2024

Advertisement

The Evolution of TAVR Explants

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward

How I Treat A Failed Evolut

A New FDA for a New Era: Innovation Demands Evolution!

TCT 1317: Preventing Sinus Sequestration in a Failed Evolut With ShortCut: A Dedicated Leaflet Modification Device

TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

The Evolution of LAAO: Innovation Trends in Technology and Imaging

TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium

AS in Women

Procedural Considerations

Case Background and Valve Selection Discussion

Case Outcome

SMART Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content